October is a month to harvest the work we’ve done throughout the year and to recognize the efforts of those who have worked tirelessly for the benefit of the brain tumor community. At our inaugural NBTS Grey Gala, we honored the lives of those who fought their own personal battles and those who have made strides for all of us. Together, those in the room raised more than $260,000 to invest in a future where brain tumors will no longer be something to fear, but to manage and ultimately cure.

Less than 24 hours later, scientists, clinicians, industry leaders and patients attended the NBTS Scientific Summit. Together, they heard about the latest developments that NBTS helped fund, and saw the trajectory of our current initiatives. This was all done with your support, and it can’t continue without you. It’s our fight, It’s Your Fight.

Defeat GBM-funded research discovers a completely new process whereby EGFR alterations which occur in the majority of GBMs fuel tumor growth, and, importantly, identifies a potential way to exploit these changes in tumor cells to treat GBM using a class of anti-cancer drugs already in development. Read More

Two announcements this week thrust the importance of funding biomedical research into the national spotlight, yet again. This Wednesday, Vice President Joe Biden stepped in front of a podium in the White House Rose Garden and made a long anticipated announcement: his decision regarding a presidential bid. However, after the Vice President revealed his plan […] Read More